Marangos N, Maier W, Merz R, Laszig R
Department of Otorhinolaryngology, Albert-Ludwigs-University, Freiburg, Germany.
Otol Neurotol. 2001 Jan;22(1):95-9. doi: 10.1097/00129492-200101000-00018.
To evaluate the auditory brainstem response (ABR) findings in cerebellopontine angle (CPA) tumors and focus on those with normal ABR results.
This was a retrospective evaluation of ABR findings. All subjects with diagnosed CPA tumors who were referred for treatment were included.
All 309 patients with radiographically confirmed (computed tomography or magnetic resonance imaging [MRI]) CPA tumors (153 before 1993 and 156 after 1993).
All patients underwent complete audiologic examination, electronystagmography, ABR testing, and ipsilateral transtympanic electrocochleography. All tumors were histologically confirmed.
The patients were categorized according to ABR results (normal or pathologic findings or no response); according to histology (vestibular schwannomas or meningiomas); and according to tumor size by MRI (small, up to 15 mm; medium, 16-25 mm; large, 26-40 mm; and very large, over 40 mm).
Normal ABR results were found in 18.4%; pathologic ABR results in 31.4%; and no response in 50.2%. Small vestibular schwannomas (under 15 mm) showed a higher incidence of normal ABR results (41.7%). CPA tumors with normal ABR results (n = 57) caused no hearing loss (n = 12), symmetrical hearing loss (n = 11), or ipsilateral hearing loss with Short Increment Sensitivity Index 100% and normal acoustic reflex (cochlear deafness, n = 34). Caloric response was normal in 59.7% of these tumors.
Because validation of ABR as screening for acoustic tumors is based on diagnosed tumors, and because MRI allows detection of very small tumors, the incidence of normal ABR increases and its sensitivity would be expected to decrease. ABR is not sufficient for early detection of small CPA tumors.
评估桥小脑角(CPA)肿瘤的听觉脑干反应(ABR)结果,并关注那些ABR结果正常的肿瘤。
这是一项对ABR结果的回顾性评估。纳入了所有被诊断为CPA肿瘤并转诊接受治疗的受试者。
所有309例经影像学证实(计算机断层扫描或磁共振成像[MRI])的CPA肿瘤患者(1993年之前153例,1993年之后156例)。
所有患者均接受了全面的听力学检查、眼震电图检查、ABR测试以及同侧经鼓膜电耳蜗图检查。所有肿瘤均经组织学确诊。
根据ABR结果(正常或病理结果或无反应)、组织学(前庭神经鞘瘤或脑膜瘤)以及MRI测量的肿瘤大小(小,最大15mm;中,16 - 25mm;大,26 - 40mm;非常大,超过40mm)对患者进行分类。
ABR结果正常的占18.4%;病理ABR结果的占31.4%;无反应的占50.2%。小的前庭神经鞘瘤(小于15mm)ABR结果正常的发生率较高(41.7%)。ABR结果正常的CPA肿瘤(n = 57)未导致听力损失(n = 12)、对称性听力损失(n = 11)或同侧听力损失伴短增量敏感指数100%且声反射正常(耳蜗性聋,n = 34)。这些肿瘤中59.7%的冷热试验反应正常。
由于ABR作为听神经瘤筛查的验证是基于已确诊的肿瘤,并且由于MRI能够检测到非常小的肿瘤,ABR结果正常的发生率增加,其敏感性预计会降低。ABR不足以早期检测小的CPA肿瘤。